Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Ital J Pediatr italian j of pediatric Volume:
Keywords : Factor VIII inhibitor development , Egyptian hemophilia    
Abstract:
Background: Hemophilia A (HA) is an X-linked recessive bleeding disorder characterized by qualitative and quantitative deficiency of factor VIII (FVIII). The development of inhibitor antibodies against FVIII is the most challenging complication of treatment. Mutations in the FVIII gene is one of the genetic factors that leads to development of FVIII inhibitors especially intron 22 inversion (Inv22). Objectives: This study was carried out to assess the frequency of Inv22 of FVIII gene in Egyptian patients with hemophilia A and its role as a risk factor for developing inhibitors. Patients and methods: Seventy-two patients with severe HA and 48 patients with moderate HA were enrolled in the current study. All patients were treated on demand with either plasma-derived factor VIII or recombinant factor VIII concentrates. Genotyping of FVIII Inv22 was performed by LD-PCR while the presence and magnitude of inhibitor activity in blood was determined by the Bethesda assay. Results: Around 23% of all hemophilia cases had positive Inv22. Intron 22 inversion mutation was detected in 6 and 33% of patients with moderate and severe HA respectively. Twenty-one cases (18%) of all hemophilic patients developed inhibitors. Thirty-7% of patients with Inv22 had inhibitor in their blood, almost all, but one, had severe HA. The risk of an inhibitor development during replacement therapy was four folds higher among Inv22 positive cases as compared with mutation negative peers (OR 4.3, 95% CI 1.6-11.9, P = 0.003). Conclusions: The prevalence of Inv22 of F VIII in Egyptian hemophiliacs is nearly like that of other population. This mutation was more frequently detected among severe hemophilic patients as compared with moderately affected peers. The presence of Inv22 mutation significantly predispose to FVIII inhibitor development.
   
     
 
       

Author Related Publications

  • Laila Metwally Ibrahim Sharif, "18. Factors associated with delayed cancer diagnosis in egyptian children.", Clin Med Insights Pediatr, 2015 More
  • Laila Metwally Ibrahim Sharif, "serum trace elements in obese Egyptian children: a case -control study", BioMed Centr, 2014 More
  • Laila Metwally Ibrahim Sharif, "Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children", W.S.&son Ltd 2012, 2012 More
  • Laila Metwally Ibrahim Sharif, "Progressive Familial Intrahepatic Cholestasis Type 3: a Novel Mutation in a Saudi Child", W, 2013 More
  • Laila Metwally Ibrahim Sharif, "Study of Non–organ‑specific Antibodies in Children with Genotype 4 Chronic Hepatitis C", Wolters kluwer/medhnow, 2013 More

Department Related Publications

  • Amal Alsayed Sehata Morssi, "20. معدلات تدفق الدم بالنسيج الضام للمبيض باستخدام الدوبلر ذو الطاقة ثلاثى الابعاد وعامل النمو للخلايا المبطنة للاوعية الدموية في متلازمة تكيس المبيض عقب تثقيب المبيض بمنظار البطن ", لايوجد, 1900 More
  • Diab Ahmed Radwan, "ارتباط عامل نمو العصب و الانترلوكين -4 و-5 في حدوث الربو الشعبى و دورهم فى تنشيط خلايا الاوزينوفيل", لايوجد, 1900 More
  • Diab Ahmed Radwan, "تاثير ثيوسلفات الصوديوم و الميلاتونين علي الاثار السميه لعقار السيزبلاتين على الاذن و الكلى و خطوره الاكسده فى الجرزان البيضاء البالغه", لايوجد, 1900 More
  • Sami Hassan Ibrahim, "دور فيروس الالتهاب الكبدي س في حدوث مرض الرثيان المفصلي.", لايوجد, 1900 More
  • Sami Hassan Ibrahim, "اهميه قياس عامل نمو خلايا بطانه الاوعيه الدمويه في مصل دم مرضي سرطان الكبد", لايوجد, 1900 More
Tweet